Recoverin anticorps (C-Term)
Aperçu rapide pour Recoverin anticorps (C-Term) (ABIN927702)
Antigène
Voir toutes Recoverin (RCVRN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Rat (Rattus), Boeuf (Vache), Chien
-
Purification
- Purified
-
Immunogène
- RCV1 antibody was raised in rabbit using the C terminal of RCV1 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
RCV1 Blocking Peptide, (ABIN939939), is also available for use as a blocking control in assays to test for specificity of this RCV1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- Recoverin (RCVRN)
-
Autre désignation
- RCV1
-
Sujet
- RCV1 is a member of the recoverin family of neuronal calcium sensors. RCV1 contains three calcium-binding EF-hand domains and may prolong the termination of the phototransduction cascade in the retina by blocking the phosphorylation of photo-activated rhodopsin. Recoverin may be the antigen responsible for cancer-associated retinopathy.The protein encoded by this gene contains four calcium-binding EF-hand domains and belongs to the recoverin family of neuronal calcium sensors. Recoverin may prolong the termination of the phototransduction cascade by blocking the phosphorylation of photo-activated rhodopsin. Recoverin may be the antigen responsible for cancer-associated retinopathy, an autoimmune disease of the retina caused by a tumor in another tissue. Synonyms: Polyclonal RCV1 antibody, Anti-RCV1 antibody.
-
Pathways
- Regulation of G-Protein Coupled Receptor Protein Signaling, Phototransduction
Antigène
-